If a company builds assets at 42.7% a year, faster than its revenue growth rate of 13% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Shenzhen Kangtai Biological Products Co's average Total Assets Growth Rate was 9.30% per year.
During the past 3 years, the average Total Assets Growth Rate was 28.20% per year.
During the past 5 years, the average Total Assets Growth Rate was 42.70% per year.
During the past 10 years, the average Total Assets Growth Rate was 34.50% per year.
During the past 12 years, Shenzhen Kangtai Biological Products Co's highest 3-Year average Total Assets Growth Rate was 57.60%. The lowest was 8.80%. And the median was 31.70%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shenzhen Kangtai Biological Products Co Total Assets Chart
Shenzhen Kangtai Biological Products Co Annual Data
Shenzhen Kangtai Biological Products Co Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Kangtai Biological Products Co (SZSE:300601) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Shenzhen Kangtai Biological Products Co's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Shenzhen Kangtai Biological Products Co Total Assets Related Terms
Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300601 has been successfully added to your 